A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection-Reference-Cited by-同舟云学术

A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection

Published:2019-04 Issue:15 Volume:98 Page:e15139
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Deng Zi-Wei,Wang Jin,Qiu Cheng-Feng,Yang Yi,Shi Zhi-Hua,Zhou Jian-Liang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference10 articles.

1. First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii;Lauretti;J Neurosurg,2017

2. Task force on management and prevention of Acinetobacter baumannii infectionsin the ICU;Garnacho-Montero;Intensive Care Med,2015

3. Adverse event profile of tigecycline: data mining of the public version of the U. S. Food and Drug Administration adverse event reporting system;Kadoyama;Biol Pharm Bull,2012

4. The insertion and management of external ventricular drains: an evidence-based consensus statement;Fried;Neurocrit Care,2016

5. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis;Tunkel;Clin Infect Dis,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases;Surgical Infections;2024-07-26

2. Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations;Antibiotics;2023-08-05

3. Intrathecal tigecycline is a safe and effective treatment for central nervous system infections;encephalitis;2023-07-10

4. A High-Performance Liquid Chromatography—Mass Spectrometry Method for Simultaneous Determination of Vancomycin, Meropenem, and Valproate in Patients with Post-Craniotomy Infection;Molecules;2023-03-07

5. The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults;Antibiotics;2022-12-19